Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Maria Franceschini
Boston Children's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
149 Medical, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Franceschini is the Subrecipient PI and is responsible for the overall design, conduct, and reporting of the research conducted under the subcontract.
Dr. Franceschini is a co-founder of 149 Medical, Inc. The company is developing NIRS-DCS technology for assessing and monitoring cerebral blood flow (CBF) and cerebral oxygen metabolism (CMRO2) in newborn infants. The research project aims to validate NIRS-DCS as a clinical tool. The company could therefore have an interest in the results of this research. The Partners Committee on Outside Activities review panel evaluated the financial interest in connection with this research project and determined that, based on the close connection between the company's interests and the research, the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
Neonatal encephalopathy continues to cause significant morbidity and the lack of a bedside tool to assess newborn brain health limits progress in neonatal care that could improve neurodevelopmental outcomes. The overall goal of this proposal is to determine if FDNIRS-DCS can screen for acute neonatal encephalopathy, assess response to treatment and predict outcomes in a population of at-risk neonates.
Filed on June 04, 2018.
Tell us what you know about Maria Franceschini's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Maria Franceschini”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | 149 Medical, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | 149 Medical, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Boston Children's Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | Dynometrics, Inc. | Value cannot be readily determined |
| Maria Franceschini | Massachusetts General Hospital | Conflict of Interest | 149 Medical, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.